Blinatumomab Consolidation in Real World

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Medical College of Wisconsin
Study ID
NCT07117136
Status
Recruiting
Apply to this trial

Conditions

  • B-Cell Acute Lymphoblastic Leukaemia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.

Key Dates

First listed
Aug 12, 2025
Start date
Aug 28, 2025
Status verified
Nov 2025
Primary completion
May 14, 2029
Completion
May 14, 2029

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Patients who received Blinatumomab Therapy
  • Arm: Patients who did not receive Blinatumomab Therapy

Primary Outcome Measure

Percentage of participants with complete remission [ Time Frame: 5 years or e.g., 1 year after closure of study ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Mayo Clinic Cancer CenterJacksonvilleFlorida32224
Talha Badar, MD
[email protected]
904-953-7556
Talha Badar, MD (PRINCIPAL_INVESTIGATOR)
Medical College of WisconsinMilwaukeeWisconsin53226
Arielle Program Manager
[email protected]
4148058745
Ehab Atallah, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic Cancer Center· Jacksonville, FLMedical College of Wisconsin· Milwaukee, WI

Related Studies